Biomarkers and risk factors for the early prediction of immune-related adverse events: a review

por Zhang, Ying, Zhang, Xiaoling, Li, Weiling, Du, Yunyi, Hu, Wenqing, Zhao, Jun
Publicado 2022

PEX13 is a potential immunotherapeutic indicator and prognostic biomarker for various tumors including PAAD

por Dong, Penggang, Du, Xuezhi, Yang, Ting, Li, Dandan, Du, Yunyi, Wei, Yaqing, Sun, Jinjin
Publicado 2023

HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives

por Li, Weiling, Zhang, Xiaoling, Du, Yunyi, Zhang, Ying, Lu, Jing, Hu, Wenqing, Zhao, Jun
Publicado 2022

Intravenous analgesia with ultra-high-dose morphine for the treatment of headache and successful withdrawal of morphine: A case report and literature review

por Zhang, Xiaoling, Zhang, Jialei, Du, Yunyi, Wang, Mei, Gao, Yangjun, Zhou, Lurong, Lu, Jing, Zhao, Jun
Publicado 2020

The clinical application value of phase angle of six parts in nutritional evaluation of tumor patients

por Zhang, Xiaoling, Zhang, Jialei, Du, Yunyi, Wu, Xiaoyu, Chang, Yali, Li, Weiling, Liu, Yaqin, Hu, Wenqing, Zhao, Jun
Publicado 2022

PD-1 inhibitor treatment in a penile cancer patient with MMR/MSI status heterogeneity: A case report

por Du, YunYi, Zhang, XiaoLing, Zhang, Ying, Li, WeiLing, Hu, WenQing, Zong, Liang, Zhao, Jun
Publicado 2022

MiR-1260b inhibitor enhances the chemosensitivity of colorectal cancer cells to fluorouracil by targeting PDCD4/IGF1

por Zhao, Jun, Cao, Jingjie, Zhou, Lurong, Du, Yunyi, Zhang, Xiaoling, Yang, Bo, Gao, Yangjun, Wang, Yu, Ma, Ning, Yang, Wei
Publicado 2018